Clinical Trial Update: Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics [Phase 4]

View source ↗

Summary

Phase 4 trial updating oral vancomycin use to prevent recurrent Clostridioides difficile infection in patients on antibiotics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• oral vancomycin (vancomycin)

Snippet

Sponsor: University of Nevada, Reno | Conditions: Clostridium Difficile Infection | Phase 4 | Status: COMPLETED